Novartis AG’s Breast Cancer Drug Femara Often Given For Infertility; May Harm Newborn, Prime Therapeutics Reports

CHICAGO (Reuters) - Three in 10 women take the common breast cancer drug Femara to treat infertility, even though it could increase risks to the baby, U.S. researchers said on Friday.

MORE ON THIS TOPIC